Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun 24;2014(6):CD000238.
doi: 10.1002/14651858.CD000238.pub2.

Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest

Faisal Ameer  1 , Kristin V Carson, Zafar A Usmani, Brian J Smith
Affiliations
Review

Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest

Faisal Ameer et al. Cochrane Database Syst Rev. .

Abstract

Background: People with chronic obstructive pulmonary disease (COPD) often become transiently hypoxaemic (low oxygen levels in blood) on exercise, necessitating oxygen therapy to improve breathlessness and exercise capacity and to reduce disability. Ambulatory oxygen therapy refers to provision of oxygen therapy during exercise and activities of daily living. Ambulatory oxygen therapy is often used by patients on long-term oxygen therapy (LTOT) during exercise or by non-LTOT users with or without resting hypoxaemia when they show evidence of exercise de-saturation and demonstrate improvement in exercise capacity with supplemental oxygen.

Objectives: To determine the longer-term efficacy of ambulatory oxygen therapy only in patients with COPD who do not meet the criteria for LTOT, with respect to improvement in exercise capacity, mortality, quality of life and other relevant measures of improvement.

Search methods: The Cochrane Airways Group Specialised Register, including MEDLINE, EMBASE and CINAHL, was searched. Online clinical trial registers, including Controlled Clinical Trials (www.controlled-trials.com), government registries (clinicaltrials.gov) and World Health Organization (WHO) registries (www.who.int/trialsearch), were screened for ongoing and recently completed studies. Bibliographies of included studies were searched for additional trials that may meet the inclusion criteria and were not retrieved by the above search strategy. Authors of identified trials were contacted to provide other published and unpublished studies. Searches were current as of November 2012.

Selection criteria: Randomised controlled trials (RCTs) that compare ambulatory oxygen therapy provided through portable oxygen cylinders/battery-powered devices or liquid oxygen canisters versus placebo air cylinders, usual medical care or co-intervention in study participants with COPD who did not meet criteria for LTOT.

Data collection and analysis: We used standard methods as expected by The Cochrane Collaboration.

Main results: Four studies met the inclusion criteria (331 participants), with two studies producing a statistically and clinically significant benefit in favour of the intervention for dyspnoea post exercise.The quality of life domain for all four included studies produced a statistically significant benefit for the subcategories of dyspnoea and fatigue, in favour of the oxygen group (dyspnoea mean difference (MD) 0.28, 95% confidence interval (CI) 0.10 to 0.45; P value 0.002; fatigue MD 0.17, 95% CI 0.04 to 0.31; P value 0.009). No evidence of any effect was reported for survival, and limited benefits were observed for exercise capacity (as measured by step test and distance walk test), with one study showing a statistically significant improvement in the number of steps taken in the oxygen group for group N-of-1 studies only. No other statistically significant benefits were observed for exercise capacity among the other trials or individual N-of-1 studies.

Authors' conclusions: In patients with COPD with moderate hypoxia, current evidence on ambulatory oxygen therapy reveals improvements in dyspnoea post exercise and in the dyspnoea and fatigue domain of quality of life. However, evidence for the clinical utility and effectiveness of ambulatory oxygen in improving mortality and exercise capacity was not evident in this review. Methodologically rigorous RCTs with sufficient power to detect a difference are required to investigate the role of ambulatory oxygen in the management of COPD.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
158 Study flow diagram.
2
2
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Ambulatory oxygen therapy versus placebo (air), Outcome 1 6MWD (cylinder air for 6MWD).
1.2
1.2. Analysis
Comparison 1 Ambulatory oxygen therapy versus placebo (air), Outcome 2 6MWD outcome (cylinder oxygen for 6MWD).
1.3
1.3. Analysis
Comparison 1 Ambulatory oxygen therapy versus placebo (air), Outcome 3 Step exercise testing (number of steps).
1.4
1.4. Analysis
Comparison 1 Ambulatory oxygen therapy versus placebo (air), Outcome 4 Mortality.
1.5
1.5. Analysis
Comparison 1 Ambulatory oxygen therapy versus placebo (air), Outcome 5 Borg score—dyspnoea (higher score worse).
1.6
1.6. Analysis
Comparison 1 Ambulatory oxygen therapy versus placebo (air), Outcome 6 Arterial oxygen saturation during exercise.
1.7
1.7. Analysis
Comparison 1 Ambulatory oxygen therapy versus placebo (air), Outcome 7 Quality of life (Chronic Respiratory Questionnaire).
1.8
1.8. Analysis
Comparison 1 Ambulatory oxygen therapy versus placebo (air), Outcome 8 SpO2.
1.9
1.9. Analysis
Comparison 1 Ambulatory oxygen therapy versus placebo (air), Outcome 9 Adverse event.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Eaton 2002 {published data only}
    1. Eaton T, Garrett JE, Young P, Fergusson W, Kolbe K, Rudkin S, et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. European Respiratory Journal 2002;20:306‐12. [DOI: 10.1183/09031936.02.00301002] - DOI - PubMed
McDonald 1995 {published data only}
    1. McDonald CF, Blyth CM, Lazarus MD, Marschner I, Barter CE. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia. American Journal of Respiratory and Critical Care Medicine 1995;152(5):1616‐9. - PubMed
Moore 2011 {published data only}
    1. Moore RP, Berlowitz DJ, Denehy L, Pretto JJ, Brazzale DJ, Sharpe K, et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax 2011;66:32‐7. - PubMed
Nonoyama 2007 {published data only (unpublished sought but not used)}
    1. Nonoyama ML, Brooks D, Guyatt GH, Goldstein RS. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. American Journal of Respiratory and Critical Care Medicine 2007;176:343‐9. [DOI: 10.1164/rccm.200702-308oc] - DOI - PubMed

References to studies excluded from this review

Bradley 2007 {published data only}
    1. Bradley JM, Lasserson T, Elborn S, Macmahon J, O'Neill B. A systematic review of randomized controlled trials examining the short‐term benefit of ambulatory oxygen in COPD. Chest 2007;131(1):278‐85. [PUBMED: 17218587] - PubMed
Casaburi 2012 {published data only}
    1. Casaburi R, Porszasz J, Hecht A, Tiep B, Albert RK, Anthonisen NR, et al. Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long‐term oxygen therapy. COPD 2012;9(1):3‐11. - PubMed
Fujimoto 2002 {published data only}
    1. Fujimoto K, Matsuzawa Y, Yamaguchi S, Koizumi T, Kubo K. Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia. Chest 2002;122(2):457‐63. [DOI: 10.1378/chest.122.2.457] - DOI - PubMed
Gorecka 1997 {published data only}
    1. Gorecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J. Effect of long term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 1997;52s:674‐9. - PMC - PubMed
Jolly 2001 {published data only}
    1. Jolly EC, Boscio V, Aguirre L, Luna CM, Berensztein S, Gené RJ. Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia. Chest 2001;120(2):437‐43. - PubMed
Lacasse 2005 {published data only}
    1. Lacasse Y, Lecours R, Pelletier C, Begin R, Maltais F. Randomised trial of ambulatory oxygen in oxygen‐dependent COPD. European Respiratory Journal 2005;25:1032‐8. - PubMed
Lilker 1975 {published data only}
    1. Lilker ES, Karnick A, Lerner L. Portable oxygen in chronic obstructive lung disease with hypoxemia and cor pulmonale. A controlled double blind cross over study. Chest 1975;68(2):236‐41. - PubMed

Additional references

ATS 1999
    1. [no authors listed]. American Thoracic Society. Dyspnea: mechanisms, assessment, and management: a consensus statement. American Journal of Respiratory and Critical Care Medicine 1999;159:321‐40. - PubMed
BTS 2006
    1. Clinical component for the home oxygen service in England and Wales. British Thoracic Society (BTS) working group on home oxygen services January 2006. www.britthoracic.org.uk.(accessed 24 June 2012).
Casanova 2008
    1. Casanova C, Cote C, Marin JM, Pinto‐Plata V, Torres JP, Aguirre‐Jaíme A, et al. Distance and oxygen desaturation during the 6‐min walk test as predictors of long‐term mortality in patients with COPD. Chest 2008;1344:746‐52. - PubMed
Garrod 2000
    1. Garrod P, Paul EA, Wedzicha JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax 2000;55:539‐43. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Vol. 5.1.0, The Cochrane Collaboration, 2011.
Katsenos 2011
    1. Katsenos S, Constantopoulos SH. Long‐term oxygen therapy in COPD: factors affecting and ways of improving patient compliance. Pulmonary Medicine 2011;2011:1‐8. - PMC - PubMed
NICE 2010
    1. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. http://guidance.nice.org.uk/CG101/Guidance/pdf/English (accessed 24 June 2012).
Rabe 2007
    1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2007;176(6):532‐5. - PubMed
Ram 2002
    1. Ram FSF, Wedzicha JA. Ambulatory oxygen for chronic obstructive pulmonary disease (Cochrane Review). Cochrane Database of Systematic Reviews 2002, Issue 2. [DOI: 10.1002/14651858.CD000238] - DOI - PubMed
Ringbaek 2002
    1. Ringbaek TJ, Viskum K, Lange P. Does long‐term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease?. European Respiratory Journal 2002;20(1):38‐42. - PubMed
Seamark 2007
    1. Seamark DA, Seamark CJ, Halpin DM. Palliative care in chronic obstructive pulmonary disease: a review for clinicians. Journal of the Royal Society of Medicine May 2007;100(5):225‐33. - PMC - PubMed
Stoller 2010
    1. Stoller JK, Panos RJ, Krachman S, Doherty DE, Make B. Oxygen therapy for patients with COPD: current evidence and the long‐term oxygen treatment trial. Chest 2010;138(1):179‐87. - PMC - PubMed
Tham 2011
    1. Tham KY, Anantham D. Ambulatory oxygen in chronic obstructive pulmonary disease. Open Journal of Respiratory Diseases 2011;1(2):14‐18. [DOI: 10.4236/ojrd.2011.12002] - DOI

MeSH terms

LinkOut - more resources